This was further supported by findings in HNSCC patient tumors with high allele frequencies of HRAS p.G12S and MAPK1 p.D321N mutations (>30-40% allele frequency) expressing low levels of p-ErbB3. The gene discussed is HRAS; the disease is head and neck squamous cell carcinoma.